Sunday, June 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Strategy’s Billion-Dollar Bitcoin Bet: Doubling Down Amid Losses

Jackson Burston by Jackson Burston
March 12, 2026
in Analysis, Bitcoin, Blockchain, Crypto Stocks
0
Strategy Stock
0
SHARES
22
VIEWS
Share on FacebookShare on Twitter

Despite carrying significant unrealized losses and watching its share price plummet over recent months, Strategy Inc. is pushing forward with an aggressive cryptocurrency accumulation strategy. The firm has just deployed another $1.28 billion into Bitcoin, raising questions about whether this persistent buying will ultimately reward its investors.

A Treasury Ambition and a Milestone Purchase

Positioning itself firmly as a Bitcoin treasury vehicle, Strategy is banking on broader institutional adoption, a trend it expects will accelerate with upcoming U.S. regulatory frameworks. In line with this expansion-focused mandate, the company executed its 100th discrete transaction since initiating its accumulation program in 2020. Between March 2 and March 8, 2026, the world’s largest institutional Bitcoin holder purchased an additional 17,994 coins.

Notably, this move was not funded from existing cash reserves. Strategy raised the entire $1.28 billion sum through capital markets, issuing both common and preferred shares to finance the purchase without impacting its operational business.

Mounting Losses and a Contrarian Bull Case

The acquisition brings Strategy’s total holdings to 738,731 Bitcoin, representing over 3.4% of the cryptocurrency’s maximum possible supply. However, the portfolio is currently underwater on paper. The average purchase price sits at $75,862 per Bitcoin, which was above the market price at the time of this latest buy. This fundamental pressure is compounded by a massive net loss of $12.6 billion reported for the fourth quarter of 2025.

Should investors sell immediately? Or is it worth buying Strategy?

The market has reflected these strains. The stock has shed approximately 50% of its value over a one-year period, with shares currently trading at €118.55—well below their 200-day moving average.

Yet, Wall Street sentiment is showing signs of a shift. Analysts at B. Riley Securities have initiated coverage with a “Buy” rating. Market strategist Fedor Shabalin argues that since last October, Strategy’s shares have fallen significantly more than Bitcoin itself. He views the current valuation level, supported by multibillion-dollar cash reserves and a digital credit platform, as an attractive entry point.

Ample Firepower for Future Purchases

The management’s roadmap remains squarely fixed on further growth. With nearly $10 billion in remaining capacity from ongoing share programs, Strategy possesses substantial dry powder for future acquisitions. This financial muscle suggests the company’s billion-dollar Bitcoin purchases are likely to continue.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from June 21 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 21.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Jackson Burston

Jackson Burston

Related Posts

STMicroelectronics Stock
Analysis

STMicroelectronics: Rally Runs Into Dividends, Dilution, and Deteriorating Cash Flow

June 21, 2026
Ethereum Stock
Bitcoin

Ethereum’s Great Divide: Record Network Activity Masks Leadership Exodus and Funding Squeeze

June 21, 2026
Bayer Stock
Analysis

Bayer Juggles a $2.45 Billion Biotech Bet and a Washington Trade Probe

June 21, 2026
Next Post
Micron Stock

Micron Technology Shares Surge on Upgraded Outlook and Expansion Plans

Palantir Stock

Palantir Ventures into Uncharted Territory with Integrity Platform

BioNTech Stock

BioNTech Navigates Leadership Shift Amidst Strategic Pivot and Financial Headwinds

Recommended

Bionxt Solutions Stock

European Patent Paves Way for BioNxt’s Multiple Sclerosis Innovation

7 months ago
Plug Power Stock

Plug Power’s Reddit CEO and a $275 Million Asset Sale Set the Stage for a Make-or-Break Earnings

2 months ago
Blue Foundry Bancorp Stock

Blue Foundry Bancorp Faces Critical Earnings Test

8 months ago
Uranium Energy Stock

Uranium Energy Faces Potential Sell-Off as Lock-Up Period Expires

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Take-Two’s Pivotal Wednesday: GTA VI Pre-Orders Arrive as Macro Data Tests the Rally

Ocugen’s CFO Bets on Her Own Stock as a Packed Conference Schedule Previews a Pivotal Summer

Arafura Rare Earths: The July 2 Vote That Could Decide Australia’s First Fully Integrated Rare Earth Mine — and a US Defense Lifeline

Lenzing Shares Rally 21% on EU Clothing Ban and Award Win, But Overbought Signals and Macro Data Loom

Cerebras Faces Its First Earnings Test: A $24.6 Billion Backlog Meets a 95x Price Tag

Record Revenue, 40% Rout: Adobe’s Freemium Gamble Leaves Investors Wanting More

Trending

STMicroelectronics Stock
Analysis

STMicroelectronics: Rally Runs Into Dividends, Dilution, and Deteriorating Cash Flow

by Jackson Burston
June 21, 2026
0

A 189% surge since January has turned STMicroelectronics into one of the hottest names in the semiconductor...

Ethereum Stock

Ethereum’s Great Divide: Record Network Activity Masks Leadership Exodus and Funding Squeeze

June 21, 2026
Bayer Stock

Bayer Juggles a $2.45 Billion Biotech Bet and a Washington Trade Probe

June 21, 2026
Take-Two Stock

Take-Two’s Pivotal Wednesday: GTA VI Pre-Orders Arrive as Macro Data Tests the Rally

June 21, 2026
Ocugen Stock

Ocugen’s CFO Bets on Her Own Stock as a Packed Conference Schedule Previews a Pivotal Summer

June 21, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • STMicroelectronics: Rally Runs Into Dividends, Dilution, and Deteriorating Cash Flow
  • Ethereum’s Great Divide: Record Network Activity Masks Leadership Exodus and Funding Squeeze
  • Bayer Juggles a $2.45 Billion Biotech Bet and a Washington Trade Probe

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com